title: A comparison of six statins on the development of intimal hyperplasia in a human vein culture model.
abstract: OBJECTIVE
  Intimal hyperplasia (IH) threatens the patency of up to 35% of saphenous vein (SV) bypass grafts. In addition to reducing cholesterol levels, statins may modulate smooth muscle cell proliferation and migration. Statins inhibit matrix metalloproteinase (MMP) activity. We therefore investigated the effect of six statins on neointimal formation and MMP activity in human SV organ culture.
  
  
  METHODS
  Human SV specimens were cultured for 14 days in the presence of six different statins and subsequently processed for measurement of neointimal thickness and MMP activity. The drug concentrations chosen corresponded to the manufacturers' Cmax.
  
  
  RESULTS
  The six statins all significantly reduced IH development (P = 0.004) in association with reduced expression of proMMP-2 and 9 (P = 0.03) and reduced activity of activated MMP-2 and 9 (P = 0.03).
  
  
  CONCLUSIONS
  This study suggests that the potential benefit of statins in reducing IH is a class effect and not confined to specific statins. The reduction of IH produced by statins may in part be due to their inhibition of MMPs.
authors.affiliation: Service de Chirugie Thoracique et Vasculaire, 1011 Lausanne Chuv, Switzerland.
authors.forename: J-M
authors.initials: JM
authors.lastname: Corpataux
authors.forename: J
authors.initials: J
authors.lastname: Naik
authors.forename: K E
authors.initials: KE
authors.lastname: Porter
authors.forename: N J M
authors.initials: NJ
authors.lastname: London
mesh_terms: D017364:Collagenases / Q000187:drug effects / Q000378:metabolism; D004792:Enzyme Precursors / Q000187:drug effects / Q000378:metabolism; D006083:Graft Occlusion, Vascular / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D006965:Hyperplasia / Q000517:prevention & control; D020778:Matrix Metalloproteinase 2 / Q000187:drug effects / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000187:drug effects / Q000378:metabolism; D012501:Saphenous Vein / Q000378:metabolism / Q000473:pathology*; D046509:Tissue Culture Techniques; D017539:Tunica Intima / Q000378:metabolism / Q000473:pathology*
chemical_list: D004792:Enzyme Precursors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D017364:Collagenases; C120487:pro-matrix metalloproteinase 9; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9